Mikrogen GmbH

MIKROGEN`s scope of business covers the development, production and distribution of genetically engineered in vitro diagnostics. The company focuses on the serology of bacterial, viral and parasitic infections as well as on auto immune diseases. Since 1989 MIKROGEN produces antigens for clinical diagnostics. The company has an excellent expertise for the development of test systems based on recombinant antigens. The company`s highly skilled and experienced employees are the key to the success of MIKROGEN. To improve the performance of clinical diagnostics constantly, more than one hundred staff members work continuously on the implementation of latest scientific results. MIKROGEN owns various patents particularly for Borrelia burgdorferi, Parvovirus B19, EBV and HCV antigens. Mikrogen GmbH founded in 1989 has in its long history grown into a company which is serving a wide range of customers in Germany as well as in more than 40 other countries around the world.